Neurology MRI

>

Latest News

Study of Ofatumumab for Multiple Sclerosis Shows ‘Profoundly Suppressed MRI Lesion Activity’
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'

April 17th 2024

The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.

FDA Clears New 7T MRI System from Siemens Healthineers
FDA Clears New 7T MRI System from Siemens Healthineers

March 27th 2024

3D MRI for Quantitative Brain Imaging Gets FDA Nod
3D MRI for Quantitative Brain Imaging Gets FDA Nod

March 27th 2024

FDA Clears Remote Scanning Support Platform for MRI, CT and PET/CT
FDA Clears Remote Scanning Support Platform for MRI, CT and PET/CT

March 25th 2024

MRI Safety: A Closer Look at Key Factors in Managing Radiofrequency Exposure
MRI Safety: A Closer Look at Key Factors In Managing Radiofrequency Exposure

March 8th 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.